Recruiting OBSERVATIONAL NCT06457776

Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs

Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs: a Cohort Prospective Study

Sponsor: Catholic University of the Sacred Heart

Conditions Bisphosphonate-Associated Osteonecrosis Bisphosphonate-Associated Osteonecrosis of the Jaw Osteonecrosis Due to Drug Osteonecrosis Due to Drugs, Jaw Osteonecrosis of the Jaw

Interventions Dental management

Updated 2 times since 2024 Last updated: Jun 17, 2024 Started: Jan 1, 2021 Primary completion: Jan 1, 2026 Completion: Jan 1, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Bisphosphonate-Associated Osteonecrosis and Bisphosphonate-Associated Osteonecrosis of the Jaw and is currently actively recruiting participants. Catholic University of the Sacred Heart leads this study, which shows 2 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Catholic University of the Sacred Heart

Data source: Catholic University of the Sacred Heart

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Roma, Italy